How much forward-looking information do public companies disclose, including on ESG themes? Do they provide targets and KPIs on themes key to long-term value creation? In this paper, we analyze the accessibility, quantity, and time frame of forward-looking information disclosed by the 25...

The local academic science base plays a dominant role in determining where and when biotechnology is adopted by existing firms or -- much more frequently -- exploited by new entrants in the U.S. In Japan this new dominant technology has almost exclusively been introduced through organizational...

We analyze how variations in contractibility affect the design of contracts in the context of biotechnology research agreements. A major concern of firms financing biotechnology research is that the R&D firms might use the funding to subsidize other projects or substitute one project for...

Firms invest differentially in the intellectual human capital required to recognize, evaluate, and utilize technological breakthroughs occurring outside the firm. Such differential investment has been crucial in explaining which incumbent pharmaceutical firms have successfully transformed their...

A rich literature argues that interorganizational networks foster learning and coordinated adaptation among their constituents, but embedded ties between organizations are not ubiquitous. What explains this heterogeneity? Acknowledging the influence of agency relationships within organizations...

In today's modern world, the impact of technology can be felt strongly. Technology has both improved life and contributed immensely to the GDP of a lot of countries. The benefit of technological advancement across several segments of society is likely to continue. However Africa is yet to...

The purpose of this research is to explore the internationalization behavior of BioTech firms producing a COVID 19 vaccine using the Born Global internationalization model as a conceptual framework. The research methodology that has been considered in this study is a qualitative, multiple-case...

The interaction between product market competition, R&D investment, and the financing choices of R&D-intensive firms on the development of innovative products is only partially understood. To motivate empirical hypotheses about this interaction, we develop a model which predicts that as...

A European Commission report into patent licensing (Radauer and Dudenbostel 2013) concluded that the technology industry out-licenses more non-core patents than the pharmaceutical industry. A literature review suggests that this variation may be due to the perceived risks associated with holding...

Scientists who make breakthrough discoveries can receive above- normal returns to their intellectual capital, with returns depending on the degree of natural excludability - that is, whether necessary techniques can be learned through written reports or instead require hands-on experience with...